Biogen
BIIB
BIIB
1,100 hedge funds and large institutions have $51.4B invested in Biogen in 2018 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 424 increasing their positions, 416 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
7% less funds holding in top 10
Funds holding in top 10: 28 → 26 (-2)
14% less capital invested
Capital invested by funds: $60B → $51.4B (-$8.57B)
34% less call options, than puts
Call options by funds: $695M | Put options by funds: $1.05B
Holders
1,100
Holding in Top 10
26
Calls
$695M
Puts
$1.05B
Top Buyers
| 1 | +$617M | |
| 2 | +$300M | |
| 3 | +$172M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$167M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$141M |
Top Sellers
| 1 | -$1.24B | |
| 2 | -$636M | |
| 3 | -$363M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$202M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$186M |